Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/9/2009 First Published: 8/1/2001


1.		Phase III Randomized Study of Selenium and Vitamin E for the Prevention of Prostate Cancer (SELECT Trial)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				55 and over (50 and over for African Americans)				NCCAM, NCI				SWOG-S0000 CAN-NCIC-S0000, CALGB-S0000, ECOG-S0000, NCCAM, NCI-P00-0172, NCT00006392, S0000

Last Modified: 9/5/2008 First Published: 2/1/2002


2.		Phase III Randomized Study of Selenium as Chemoprevention of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				40 and over				NCI				SWOG-S9917 CALGB-70004, ECOG-SWOG-S9917, NCI-P02-0203, NCT00030901

Last Modified: 10/1/1988


3.		Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				40 to 69								DCPC-CPSB-11204

Last Modified: 9/3/2008 First Published: 6/23/2003


4.		Phase III Randomized Study of Vitamin E, Selenium, and Soy Protein Isolate in Patients With High-Grade Prostatic Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				Not specified				Other				CAN-NCIC-PRP1 NCT00064194, PRP1

Last Modified: 1/15/2007 First Published: 7/1/2001


5.		Phase II Pilot Randomized Study of Selenium Versus Observation Only Before Radical Prostatectomy in Patients With Primary Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention, Treatment				Completed				Not specified				NCI				SWOG-S9812 NCI-P01-0182

Last Modified: 11/1/2000 First Published: 11/1/2000


6.		Phase I Randomized Study of Selenium With or Without Vitamin E for the Prevention of Lung Cancer in Smokers (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Closed				18 to 70				NCI				KUMC-7159-97 NCI-P00-0152

Last Modified: 12/10/2008 First Published: 5/23/2005


7.		Phase I Study of Irinotecan and Selenium in Patients With Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Other				RPCI-I-32804 NCT00112892

Last Modified: 10/22/2008 First Published: 9/16/2005


8.		Phase I Randomized Pilot Study of Selenium in Patients Undergoing Brachytherapy for Stage I or II Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				Any age				Other				RPCI-I-14603 NCT00217516

Last Modified: 6/12/2007 First Published: 6/1/2000


9.		Pilot Randomized Chemoprevention Study of Selenium and Celecoxib, Alone or in Combination, in Patients With Esophageal Squamous Dysplasia Who are Residing in Linxian, People's Republic of China

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Closed				40 to 69 at time of screening				NCI				NCI-OH95-C-N026 NCI-P00-0157, NCT00005885

Last Modified: 3/1/2002 First Published: 8/1/2001


10.		Pilot Randomized Study of Selenium as Chemoprevention of Cancer (Summary Last Modified 03/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Closed				60 to 74				Other				SURREY-UK-PRECISE EU-20113, NCT00022165

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute